FDA has announced one guidance specified in the imaging study, “Clinical Trial Imaging Endpoint Process Standards” in 2018. In this Part 2, we share how we implement FDA guidance into our imaging study process.
Please feel free to contact us
We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.
With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.